Furthermore, TP53 mutations and functional loss similarly accelerate tumor progression, notably resulting in highly invasive mesothelioma subtypes predominantly affecting young female patients and correlating with poor clinical outcomes [23]. This evidence concerns the gene TP53 and neoplasm.